Bin Zhao

机构：Merck & Co., Inc., Rahway, NJ, USA (United States), Xiamen University, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, First Affiliated Hospital of Xiamen University, Henan Medical University · ORCID：0000-0001-8555-523X

发表论文 131 篇 · 总被引 2211 次 · h-index 26

代表论文

• Drug-induced pancreatitis: a real-world analysis of the FDA Adverse Event Reporting System and network pharmacology (2025 · Frontiers in Pharmacology · 被引 12)
• Pneumatosis intestinalis post steroid use in a patient with immune-related adverse events: Case report, literature review and FAERS analysis (2023 · Frontiers in Pharmacology · 被引 11)
• Efficacy and safety of sedation with dexmedetomidine in adults undergoing gastrointestinal endoscopic procedures: systematic review and meta-analysis of randomized controlled trials (2023 · Frontiers in Pharmacology · 被引 10)
• Clopidogrel as a Distinctive Cause of Insulin Autoimmune Syndrome: A Systematic Case Review (2023 · Diabetes Metabolic Syndrome and Obesity · 被引 9)
• Immune Checkpoint Inhibitors-Associated Diabetes and Ketoacidosis Were Found in FDA Adverse Event Reporting System: A Real-World Evidence Database Study (2024 · Endocrine Practice · 被引 8)
• Hypoglycemia as a potential risk for patients taking clopidogrel: A systematic review and meta-analysis (2023 · Frontiers in Endocrinology · 被引 8)